CICC Capital, Lyzz Capital, CITIC Securities Investment, and Huge Capital led a CNY1.13b (approximately USD160m) series C for China-based drug developer Mabworks, with participation from SDIC Fund, Lake Bleu Capital, BoCom International, Beijing E-Town International Investment & Development, Sealand Innovation, and Yuexiu Enterprises. Read more